The Gastroenterology and Hepatology seeks adults ages 18 to 75 with Primary Biliary Cholangitis (PBC) for a research study. The purpose of the study is to see if a new drug (sarogliazar) is effective at improving the lab results for patients with PBC.
Study involves taking an experimental medicine/placebo daily, blood draws, fibroscan, EKGs, and abdominal ultrasounds. This study involves at least 15 visits at UVA over approximately 59 weeks. Each visit lasting about 1 1/2 hours.
Study-related (insert exams, tests and experimental medication) provided free of charge.
$75/visit